Dried biological compositions and methods thereof
US-2024349730-A1 · Oct 24, 2024 · US
US2017096658A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2017096658-A1 |
| Application number | US-201615380104-A |
| Country | US |
| Kind code | A1 |
| Filing date | Dec 15, 2016 |
| Priority date | Mar 10, 2011 |
| Publication date | Apr 6, 2017 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A composition comprising mesoporous aggregates of magnetic nanoparticles and free-radical producing enzyme (i.e., enzyme-bound mesoporous aggregates), wherein the mesoporous aggregates of magnetic nanoparticles have mesopores in which the free-radical-producing enzyme is embedded. Methods for synthesizing the enzyme-bound mesoporous aggregates are also described. Processes that use said enzyme-bound mesoporous aggregates for depolymerizing lignin, removing aromatic contaminants from water, and polymerizing monomers polymerizable by a free-radical reaction are also described.
Opening claim text (preview).
1 .- 47 . (canceled) 48 . A composition comprising lactoperoxidase immobilized within mesoporous aggregates of magnetic nanoparticles, wherein said mesoporous aggregates of magnetic nanoparticles have mesopores in which said lactoperoxidase is embedded, wherein said mesopores are located between magnetic nanoparticles in said aggregates of magnetic nanoparticles, and wherein said mesopores and aggregates of magnetic nanoparticles in said mesoporous aggregates are simultaneously produced by a self-assembly process in which said lactoperoxidase and magnetic nanoparticles are combined in solution. 49 . The composition of claim 1 , wherein said mesoporous aggregates of magnetic nanoparticles have an iron oxide composition. 50 . The composition of claim 1 , wherein said mesoporous aggregates of magnetic nanoparticles have a magnetic nanoparticle size distribution in which at least 90% of magnetic nanoparticles have a size of at least 3 nm and up to 30 nm, and an aggregated particle size distribution in which at least 90% of said mesoporous aggregates of magnetic nanoparticles have a size of at least 10 nm and up to 500 nm. 51 . The composition of claim 1 , wherein said mesoporous aggregates of magnetic nanoparticles possess a saturated magnetization of at least 10 emu/g. 52 . The composition of claim 1 , wherein said mesoporous aggregates of magnetic nanoparticles possess a remanent magnetization up to 5 emu/g. 53 . The composition of claim 1 , wherein said lactoperoxidase is contained in said mesoporous aggregates of magnetic nanoparticles in up to 100% of saturation capacity. 54 . The composition of claim 1 , wherein said mesopores are characterized by a pore size distribution in which at least 90% of said pore volume is attributed to pores having a pore size of at least 2 nm and up to 20 nm. 55 . The composition of claim 1 , wherein said mesopores are characterized by a pore size distribution in which at least 95% of said pore volume is attributed to pores having a pore size of at least 2 nm and up to 20 nm. 56 . The composition of claim 1 , further comprising an oxidase. 57 . The composition of claim 9 , wherein said oxidase is glucose oxidase. 58 . The composition of claim 1 , wherein said mesoporous aggregates of magnetic nanoparticles and lactoperoxidase reside within submicrometric particles having a size of at least 20 nanometers. 59 . A composition comprising an enzyme immobilized within mesoporous aggregates of magnetic nanoparticles, wherein said mesoporous aggregates of magnetic nanoparticles have mesopores in which said enzyme is embedded, wherein said mesopores are located between magnetic nanoparticles in said aggregates of magnetic nanoparticles, and wherein said mesopores and aggregates of magnetic nanoparticles in said mesoporous aggregates are simultaneously produced by a self-assembly process in which said enzyme and magnetic nanoparticles are combined in solution, wherein said enzyme is selected from the group consisting of EC 1.1.2, EC 1.10.2, EC 1.14 oxidoreductase, cytochrome-b5 reductase, cytochrome-c reductase, and cytochrome-c peroxidase. 60 . The composition of claim 12 , wherein said mesoporous aggregates of magnetic nanoparticles have an iron oxide composition. 61 . The composition of claim 12 , wherein said mesoporous aggregates of magnetic nanoparticles have a magnetic nanoparticle size distribution in which at least 90% of magnetic nanoparticles have a size of at least 3 nm and up to 30 nm, and an aggregated particle size distribution in which at least 90% of said mesoporous aggregates of magnetic nanoparticles have a size of at least 10 nm and up to 500 nm. 62 . The composition of claim 12 , wherein said mesoporous aggregates of magnetic nanoparticles possess a saturated magnetization of at least 10 emu/g. 63 . The composition of claim 12 , wherein said mesoporous aggregates of magnetic nanoparticles possess a remnant magnetization up to 5 emu/g. 64 . The composition of claim 12 , wherein said enzyme is contained in said mesoporous aggregates of magnetic nanoparticles in up to 100% of saturation capacity. 65 . The composition of claim 12 , wherein said mesopores are characterized by a pore size distribution in which at least 95% of said pore volume is attributed to pores having a pore size of at least 2 nm and up to 20 nm. 66 . The composition of claim 12 , wherein said mesopores are characterized by a pore size distribution in which at least 90% of said pore volume is attributed to pores having a pore size of at least 2 nm and up to 20 nm.
Lignin peroxidase (1.11.1.14) · CPC title
acting on hydrogen peroxide as acceptor (1.11) · CPC title
Cytochrome-c peroxidase (1.11.1.5) · CPC title
Manganese peroxidase (1.11.1.13) · CPC title
Glucose oxidase (1.1.3.4) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.